Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Efficacy of Mycobacterium vaccae and vitamin D combination therapy in initial smear-negative pulmonary tuberculosis: a prospective study

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this prospective cohort study, 391 patients with initial smear-negative pulmonary tuberculosis were consecutively enrolled and followed for 4 months.

Source: Abstract.

Patients were assigned to one of three treatment groups: standard anti-tuberculosis therapy (control), standard therapy plus M.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Efficacy of Mycobacterium vaccae and vitamin D combination therapy in initial smear-negative pulmonary tuberculosis: a prospective study

Cohort study · Frontiers in Medicine · 2026

Original publication title

Efficacy of Mycobacterium vaccae and vitamin D combination therapy in initial smear-negative pulmonary tuberculosis: a prospective study

Renkui Gu; Luyao Wang

Copyright © 2026 Gu and Wang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Adjunctive therapy with M. vaccae and vitamin D enhances immune function and improves clinical outcomes in initial smear-negative PTB, suggesting a synergistic immunotherapeutic effect.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To evaluate the efficacy of adjunctive Mycobacterium vaccae (M. vaccae) and vitamin D in patients with initial smear-negative pulmonary tuberculosis (PTB) and to explore their effects on immune responses.

Source: Purpose

Abstract: What methods does the paper describe?

In this prospective cohort study, 391 patients with initial smear-negative pulmonary tuberculosis were consecutively enrolled and followed for 4 months. Patients were assigned to one of three treatment groups: standard anti-tuberculosis therapy (control), standard therapy plus M. vaccae vaccination, and standard therapy combined with M. vaccae and vitamin D. Cytokine levels [interferon-γ (IFN-γ), interleukin-4 (IL-4), IL-17, IL-10], T cell subset ratios [Th1/Th2, Th17/regulatory T cells (Treg)], and clinical outcomes were prospectively assessed.

Source: Methods

Abstract: Results

The combined therapy group showed significant increases in IFN-γ and Th1/Th2 ratio, and decreases in IL-4, IL-17, IL-10, and an increase in the Th17/Treg ratio, indicating a shift toward Th1-dominant immunity. Clinically, lesion absorption (54.33%) and cavity closure (71.13%) rates were highest in the combined group, with a total effective rate of 89.76%, surpassing the control (76.12%) and M. vaccae (79.23%) groups (p < 0.05).

Source: Results

Abstract: Conclusion

Adjunctive therapy with M. vaccae and vitamin D enhances immune function and improves clinical outcomes in initial smear-negative PTB, suggesting a synergistic immunotherapeutic effect.

Source: Conclusion
Authors’ abstract

Purpose

To evaluate the efficacy of adjunctive Mycobacterium vaccae (M. vaccae) and vitamin D in patients with initial smear-negative pulmonary tuberculosis (PTB) and to explore their effects on immune responses.

Methods

In this prospective cohort study, 391 patients with initial smear-negative pulmonary tuberculosis were consecutively enrolled and followed for 4 months. Patients were assigned to one of three treatment groups: standard anti-tuberculosis therapy (control), standard therapy plus M. vaccae vaccination, and standard therapy combined with M. vaccae and vitamin D. Cytokine levels [interferon-γ (IFN-γ), interleukin-4 (IL-4), IL-17, IL-10], T cell subset ratios [Th1/Th2, Th17/regulatory T cells (Treg)], and clinical outcomes were prospectively assessed.

Results

The combined therapy group showed significant increases in IFN-γ and Th1/Th2 ratio, and decreases in IL-4, IL-17, IL-10, and an increase in the Th17/Treg ratio, indicating a shift toward Th1-dominant immunity. Clinically, lesion absorption (54.33%) and cavity closure (71.13%) rates were highest in the combined group, with a total effective rate of 89.76%, surpassing the control (76.12%) and M. vaccae (79.23%) groups (p < 0.05).

Conclusion

Adjunctive therapy with M. vaccae and vitamin D enhances immune function and improves clinical outcomes in initial smear-negative PTB, suggesting a synergistic immunotherapeutic effect.

Publication and source details

Original title: Efficacy of Mycobacterium vaccae and vitamin D combination therapy in initial smear-negative pulmonary tuberculosis: a prospective study

Renkui Gu; Luyao Wang

Frontiers in Medicine · 2026

* Correspondence: Luyao Wang, luyaowangkhysne@126.comCopyright © 2026 Gu and Wang.2026Gu and Wanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:44:47.741656+00:00

DOI: 10.3389/fmed.2026.1778652 · PMC13143983